Urological Cancer: Clinical Advances in Personalized Therapy
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: 25 May 2025 | Viewed by 246
Special Issue Editors
Interests: minimally invasive surgery; RARP; RAPN; RARC; prostate cancer; renal cancer; urothelial cancer; robotic platforms
Interests: diagnosis and treatment of urologic malignancies; robotic surgery; surgical training
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, the field of urology has witnessed a transformative shift towards minimally invasive surgical techniques, with robot-assisted surgery at the forefront of this evolution. This innovation has expanded the scope of minimally invasive procedures, extending its applications from oncological treatments to the management of benign diseases. At the same time, significant development has occurred in terms of pharmacological approaches, with the advent of novel drugs designed to target various urologic malignancies with unprecedented precision.
Against this backdrop, we are excited to announce this Special Issue dedicated to showcasing the latest clinical advancements in pursuing personalized therapy for urological tumors. We invite contributions that not only highlight technological and therapeutic breakthroughs but also shed light on how these developments are paving the way for customized treatment plans tailored to each patient’s unique needs.
Dr. Angelo Mottaran
Dr. Marco Paciotti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- minimally invasive surgery
- robot-assisted surgery
- immunotherapy
- prostate cancer
- renal cancer
- urothelial cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
